메뉴 건너뛰기




Volumn 2, Issue 1, 2002, Pages 59-66

Lipids in Type 2 Diabetes

Author keywords

Coronary heart disease; lipids; lipoproteins; type 2 diabetes

Indexed keywords

ANTILIPEMIC AGENT; CARDIOVASCULAR AGENT; CLOFIBRIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LIPOPROTEIN;

EID: 27744444122     PISSN: 15289648     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-23096     Document Type: Article
Times cited : (13)

References (50)
  • 1
    • 0023090431 scopus 로고
    • Diabetes and atherosclerosis: an epidemiologic view
    • Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987;3: 463–524
    • (1987) Diabetes Metab Rev , vol.3 , pp. 463-524
    • Pyörälä, K.1    Laakso, M.2    Uusitupa, M.3
  • 2
    • 0032560807 scopus 로고    scopus 로고
    • Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    • Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229–234
    • (1998) N Engl J Med , vol.339 , pp. 229-234
    • Haffner, S.M.1    Lehto, S.2    Rönnemaa, T.3
  • 3
    • 0031439090 scopus 로고    scopus 로고
    • Epidemiology of macrovascular disease in diabetes
    • Laakso M, Lehto S. Epidemiology of macrovascular disease in diabetes. Diabetes Rev 1997;5:294–315
    • (1997) Diabetes Rev , vol.5 , pp. 294-315
    • Laakso, M.1    Lehto, S.2
  • 4
    • 0033533596 scopus 로고    scopus 로고
    • Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association
    • Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999;100: 1134–1146
    • (1999) Circulation , vol.100 , pp. 1134-1146
    • Grundy, S.M.1    Benjamin, I.J.2    Burke, G.L.3
  • 5
    • 0037903801 scopus 로고    scopus 로고
    • Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group
    • Miettinen H, Lehto S, Salomaa V, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21:69–75
    • (1998) Diabetes Care , vol.21 , pp. 69-75
    • Miettinen, H.1    Lehto, S.2    Salomaa, V.3
  • 6
    • 0029057589 scopus 로고
    • Insulin resistance and lipoprotein metabolism
    • Taskinen M-R. Insulin resistance and lipoprotein metabolism. Curr Opin Lipidol 1995;6:153–160
    • (1995) Curr Opin Lipidol , vol.6 , pp. 153-160
    • Taskinen, M.-R.1
  • 7
    • 0026661466 scopus 로고
    • Early abnormalities in coronary heart disease risk factors in relatives of subjects with noninsulin-dependent diabetes
    • Sarlund H, Pyörälä K, Penttilä I, et al. Early abnormalities in coronary heart disease risk factors in relatives of subjects with noninsulin-dependent diabetes. Arterioscler Thromb 1992; 12:657–663
    • (1992) Arterioscler Thromb , vol.12 , pp. 657-663
    • Sarlund, H.1    Pyörälä, K.2    Penttilä, I.3
  • 8
    • 0029760006 scopus 로고    scopus 로고
    • Insulin resistance and coronary heart disease
    • Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidol 1996;7:217–226
    • (1996) Curr Opin Lipidol , vol.7 , pp. 217-226
    • Laakso, M.1
  • 9
    • 2542507751 scopus 로고    scopus 로고
    • Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men
    • Lempiäinen P, Mykkänen L, Pyörälä K, et al. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 1999;100:123–128
    • (1999) Circulation , vol.100 , pp. 123-128
    • Lempiäinen, P.1    Mykkänen, L.2    Pyörälä, K.3
  • 10
    • 0034002064 scopus 로고    scopus 로고
    • Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes
    • Lehto S, Rönnemaa T, Pyörälä K, et al. Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia 2000;43:148–155
    • (2000) Diabetologia , vol.43 , pp. 148-155
    • Lehto, S.1    Rönnemaa, T.2    Pyörälä, K.3
  • 11
    • 0028179070 scopus 로고
    • Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects
    • Mykkänen L, Kuusisto J, Haffner SM, et al. Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscler Thromb 1994;14:518–526
    • (1994) Arterioscler Thromb , vol.14 , pp. 518-526
    • Mykkänen, L.1    Kuusisto, J.2    Haffner, S.M.3
  • 12
    • 0029151577 scopus 로고
    • Prospective study on small LDLs as a risk factor for noninsulin dependent diabetes mellitus in elderly men and women
    • Austin MA, Mykkänen L, Kuusisto J, et al. Prospective study on small LDLs as a risk factor for noninsulin dependent diabetes mellitus in elderly men and women. Circulation 1995; 92:1770–1778
    • (1995) Circulation , vol.92 , pp. 1770-1778
    • Austin, M.A.1    Mykkänen, L.2    Kuusisto, J.3
  • 13
    • 0024437162 scopus 로고
    • Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in noninsulin-dependent diabetic patients
    • Rönnemaa T, Laakso M, Kallio V, et al. Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in noninsulin-dependent diabetic patients. Am J Epidemiol 1989;130:632–645
    • (1989) Am J Epidemiol , vol.130 , pp. 632-645
    • Rönnemaa, T.1    Laakso, M.2    Kallio, V.3
  • 14
    • 0023907781 scopus 로고
    • Atherosclerotic vascular disease and its risk factors in noninsulin-dependent diabetic and nondiabetic subjects in Finland
    • Laakso M, Rönnemaa T, Pyörälä K, et al. Atherosclerotic vascular disease and its risk factors in noninsulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 1988;11:449–463
    • (1988) Diabetes Care , vol.11 , pp. 449-463
    • Laakso, M.1    Rönnemaa, T.2    Pyörälä, K.3
  • 15
    • 0025903738 scopus 로고
    • Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population
    • Harris MI.Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population. Diabetes Care 1991;14:366–374
    • (1991) Diabetes Care , vol.14 , pp. 366-374
    • Harris, M.I.1
  • 16
    • 0024386568 scopus 로고
    • Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey
    • Stern MP, Patterson JK, Haffner SM, et al. Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey. JAMA 1989;262:360–364
    • (1989) JAMA , vol.262 , pp. 360-364
    • Stern, M.P.1    Patterson, J.K.2    Haffner, S.M.3
  • 17
    • 0028801390 scopus 로고
    • Epidemiology of diabetic dyslipidemia
    • Laakso M. Epidemiology of diabetic dyslipidemia. Diabetes Rev 1995;3:408–422
    • (1995) Diabetes Rev , vol.3 , pp. 408-422
    • Laakso, M.1
  • 18
    • 0027184794 scopus 로고
    • LDL subclass phenotypes and the insulin resistance syndrome in women
    • Selby JV, Austin MA, Newman B, et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993;88:381–387
    • (1993) Circulation , vol.88 , pp. 381-387
    • Selby, J.V.1    Austin, M.A.2    Newman, B.3
  • 19
    • 0025677461 scopus 로고
    • Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis
    • Barakat HA, Carpenter JW, McLendon VD, et al. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis. Diabetes 1990;39:1527–1533
    • (1990) Diabetes , vol.39 , pp. 1527-1533
    • Barakat, H.A.1    Carpenter, J.W.2    McLendon, V.D.3
  • 20
    • 0027499264 scopus 로고
    • Lipoprotein abnormalities in well-treated type II diabetic patients
    • Manzato E, Zambon A, Lapolla A, et al. Lipoprotein abnormalities in well-treated type II diabetic patients. Diabetes Care 1993;16:469–475
    • (1993) Diabetes Care , vol.16 , pp. 469-475
    • Manzato, E.1    Zambon, A.2    Lapolla, A.3
  • 21
    • 0344789250 scopus 로고
    • Lipid advanced glycosylation: pathway for lipid oxidation in vivo
    • Bucala R, Makita Z, Koschinsky T, et al. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 1993;91:9441–9445
    • (1993) Proc Natl Acad Sci USA , vol.91 , pp. 9441-9445
    • Bucala, R.1    Makita, Z.2    Koschinsky, T.3
  • 22
    • 0023213349 scopus 로고
    • Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population
    • Abbott WG, Lillioja S, Young AA, et al. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes 1987;36:897–904
    • (1987) Diabetes , vol.36 , pp. 897-904
    • Abbott, W.G.1    Lillioja, S.2    Young, A.A.3
  • 23
    • 0023789266 scopus 로고
    • Relationship between lipoprotein levels and in vivo insulin action in normal white young white men
    • Garg A, Helderman JH, Koffler M, et al. Relationship between lipoprotein levels and in vivo insulin action in normal white young white men. Metabolism 1988;37:982–987
    • (1988) Metabolism , vol.37 , pp. 982-987
    • Garg, A.1    Helderman, J.H.2    Koffler, M.3
  • 24
    • 0025364118 scopus 로고
    • Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance
    • Laakso M, Sarlund H, Mykkänen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990;10:223–231
    • (1990) Arteriosclerosis , vol.10 , pp. 223-231
    • Laakso, M.1    Sarlund, H.2    Mykkänen, L.3
  • 25
    • 0033536189 scopus 로고    scopus 로고
    • Insulin resistance and lipid metabolism
    • Howard BV. Insulin resistance and lipid metabolism. Am J Cardiol 1999;84:28J-32J
    • (1999) Am J Cardiol , vol.84 , pp. 28J-32J
    • Howard, B.V.1
  • 26
    • 0023033051 scopus 로고
    • Effects of NIDDM on very low-density lipoprotein triglyceride and apolipoprotein B metabolism: studies before and after sulfonylurea therapy
    • Taskinen MR, Beltz WF, Harper I, et al. Effects of NIDDM on very low-density lipoprotein triglyceride and apolipoprotein B metabolism: studies before and after sulfonylurea therapy. Diabetes 1986;35:1268–1277
    • (1986) Diabetes , vol.35 , pp. 1268-1277
    • Taskinen, M.R.1    Beltz, W.F.2    Harper, I.3
  • 27
    • 0019739196 scopus 로고
    • Diabetic hypertriglyceridaemia: evidence for three clinical syndromes
    • suppl 2
    • Reaven GM, Greenfield MS. Diabetic hypertriglyceridaemia: evidence for three clinical syndromes. Diabetes 1981;30(suppl 2):66–75
    • (1981) Diabetes , vol.30 , pp. 66-75
    • Reaven, G.M.1    Greenfield, M.S.2
  • 28
    • 0025017273 scopus 로고
    • Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and noninsulindependent diabetes
    • Laakso M, Pyörälä K. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and noninsulindependent diabetes. Metabolism 1988;39:117–122
    • (1988) Metabolism , vol.39 , pp. 117-122
    • Laakso, M.1    Pyörälä, K.2
  • 29
    • 0025857172 scopus 로고
    • Fasting hypertriglyceridaemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities
    • Lewis GF, O'Meara NM, Soltys PA, et al. Fasting hypertriglyceridaemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 1991;72:934–944
    • (1991) J Clin Endocrinol Metab , vol.72 , pp. 934-944
    • Lewis, G.F.1    O'Meara, N.M.2    Soltys, P.A.3
  • 30
    • 0027406191 scopus 로고
    • Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
    • for the Multiple Risk Factor Intervention Trial Research Group
    • Stamler J, Vaccaro O, Neaton JD, et al., for the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434–444
    • (1993) Diabetes Care , vol.16 , pp. 434-444
    • Stamler, J.1    Vaccaro, O.2    Neaton, J.D.3
  • 31
    • 0018341014 scopus 로고
    • Diabetes and cardiovascular risk factors: the Framingham Study
    • Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 1979;59:8–13
    • (1979) Circulation , vol.59 , pp. 8-13
    • Kannel, W.B.1    McGee, D.L.2
  • 32
    • 0022313241 scopus 로고
    • Mortality and associated risk factors in diabetics
    • suppl 272
    • Jarrett RJ, Shipley MJ. Mortality and associated risk factors in diabetics. Acta Endocrinol 1985;110(suppl 272):21–26
    • (1985) Acta Endocrinol , vol.110 , pp. 21-26
    • Jarrett, R.J.1    Shipley, M.J.2
  • 33
    • 0034016466 scopus 로고    scopus 로고
    • LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL. The Strong Heart Study
    • Howard BV, Robbins DC, Sievers ML, et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL. The Strong Heart Study. Arterioscler Thromb Vasc Biol 2000;20: 830–835
    • (2000) Arterioscler Thromb Vasc Biol , vol.20 , pp. 830-835
    • Howard, B.V.1    Robbins, D.C.2    Sievers, M.L.3
  • 34
    • 0023930868 scopus 로고
    • Report of the National Cholesterol Education Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults
    • National Cholesterol Education Program Expert Panel, National Heart, Lung, and Blood Institute. Report of the National Cholesterol Education Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988;148:36–69
    • (1988) Arch Intern Med , vol.148 , pp. 36-69
  • 35
    • 0032892463 scopus 로고    scopus 로고
    • Management of dyslipidemia in adults with diabetes
    • suppl1
    • American Diabetes Association. Management of dyslipidemia in adults with diabetes. Diabetes Care 1999;22(suppl1):S56-S59
    • (1999) Diabetes Care , vol.22 , pp. S56-S59
  • 36
    • 0020566115 scopus 로고
    • The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study
    • West KM, Ahuja MM, Bennett PH, et al. The role of circulating glucose and triglyceride concentrations and their interactions with other “risk factors” as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care 1983;6:361–369
    • (1983) Diabetes Care , vol.6 , pp. 361-369
    • West, K.M.1    Ahuja, M.M.2    Bennett, P.H.3
  • 37
    • 0024333622 scopus 로고
    • Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study
    • Fontbonne A, Eschwege E, Cambien F, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989;32:300–304
    • (1989) Diabetologia , vol.32 , pp. 300-304
    • Fontbonne, A.1    Eschwege, E.2    Cambien, F.3
  • 38
    • 1842301672 scopus 로고    scopus 로고
    • Dyslipidemia and hyperglycemia predict coronary heart disease events in middleaged patients with NIDDM
    • Lehto S, Rönnemaa T, Haffner SM, et al. Dyslipidemia and hyperglycemia predict coronary heart disease events in middleaged patients with NIDDM. Diabetes 1997;48:1354–1359
    • (1997) Diabetes , vol.48 , pp. 1354-1359
    • Lehto, S.1    Rönnemaa, T.2    Haffner, S.M.3
  • 39
    • 0032515775 scopus 로고    scopus 로고
    • Risk factors for coronary artery disease in noninsulin-dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS 23)
    • for the United Kingdom Prospective Diabetes Study Group
    • Turner RC, Millns H, Neil HA, et al., for the United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in noninsulin-dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS 23). BMJ 1998;316:823–828
    • (1998) BMJ , vol.316 , pp. 823-828
    • Turner, R.C.1    Millns, H.2    Neil, H.A.3
  • 40
    • 0032572086 scopus 로고    scopus 로고
    • Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
    • for the AFCAPS/TexCAPS Research Group
    • Downs JR, Clearfield M, Weis S, et al., for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA 1998;279:1615–1622
    • (1998) JAMA , vol.279 , pp. 1615-1622
    • Downs, J.R.1    Clearfield, M.2    Weis, S.3
  • 41
    • 1842326783 scopus 로고    scopus 로고
    • Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
    • for the Scandinavian Simvastatin Survival Study (4S) Group
    • Pyörälä K, Pedersen TR, Kjekshus J, et al., for the Scandinavian Simvastatin Survival Study (4S) Group. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997;20:614–620
    • (1997) Diabetes Care , vol.20 , pp. 614-620
    • Pyörälä, K.1    Pedersen, T.R.2    Kjekshus, J.3
  • 42
    • 0032497945 scopus 로고    scopus 로고
    • Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels. Subgroup analyses in the Cholesterol and Recurrent Events (CARE) Trial
    • for the CARE Investigators
    • Goldberg RB, Mellies MJ, Sacks FM, et al., for the CARE Investigators. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels. Subgroup analyses in the Cholesterol and Recurrent Events (CARE) Trial. Circulation 1998;98:2513–2519
    • (1998) Circulation , vol.98 , pp. 2513-2519
    • Goldberg, R.B.1    Mellies, M.J.2    Sacks, F.M.3
  • 43
    • 0032487931 scopus 로고    scopus 로고
    • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
    • The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349–1357
    • (1998) N Engl J Med , vol.339 , pp. 1349-1357
  • 44
    • 0344258474 scopus 로고    scopus 로고
    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes. The Post Coronary Artery Bypass Graft Trial
    • Hoogwerf BJ, Waness A, Cressman M, et al. Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes. The Post Coronary Artery Bypass Graft Trial. Diabetes 1999; 48:1289–1294
    • (1999) Diabetes , vol.48 , pp. 1289-1294
    • Hoogwerf, B.J.1    Waness, A.2    Cressman, M.3
  • 45
    • 0026710526 scopus 로고
    • Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study
    • Koskinen P, Mänttäri M, Manninen V, et al. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 1992;15:820–825
    • (1992) Diabetes Care , vol.15 , pp. 820-825
    • Koskinen, P.1    Mänttäri, M.2    Manninen, V.3
  • 46
    • 0033527030 scopus 로고    scopus 로고
    • Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
    • for the Veterans Affairs High-density Lipoprotein Cholesterol Intervention Trial Study Group
    • Rubins HB, Robins SJ, Collins D, et al., for the Veterans Affairs High-density Lipoprotein Cholesterol Intervention Trial Study Group. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 1999;341:410–418
    • (1999) N Engl J Med , vol.341 , pp. 410-418
    • Rubins, H.B.1    Robins, S.J.2    Collins, D.3
  • 47
    • 0035941990 scopus 로고    scopus 로고
    • Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
    • Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001:357:905–910
    • (2001) Lancet , vol.357 , pp. 905-910
  • 48
    • 0032572043 scopus 로고    scopus 로고
    • Antiatherothrombotic properties of statins. Implications for cardiovascular event reduction
    • Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins. Implications for cardiovascular event reduction. JAMA 1998;279:1643–1650
    • (1998) JAMA , vol.279 , pp. 1643-1650
    • Rosenson, R.S.1    Tangney, C.C.2
  • 49
    • 0032816777 scopus 로고    scopus 로고
    • Peroxisome proliferatoractivated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis
    • Fruchart JC, Durietz P, Staels B. Peroxisome proliferatoractivated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr Opin Lipidol 1999;10:245–257
    • (1999) Curr Opin Lipidol , vol.10 , pp. 245-257
    • Fruchart, J.C.1    Durietz, P.2    Staels, B.3
  • 50
    • 0031964325 scopus 로고    scopus 로고
    • Management of dyslipidemia in adults with diabetes
    • Haffner SM: Management of dyslipidemia in adults with diabetes. Diabetes Care 1998:21:160–1678
    • (1998) Diabetes Care , vol.21 , pp. 160-1678
    • Haffner, S.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.